Sort by
Refine Your Search
-
the discovery of antibiotics to the structure of DNA, the gene-editing tool CRISPR-Cas9, and modern pharmacotherapies such as GLP-1-based drugs. Yet one fundamental question remains unanswered: Do
-
areas & Group Leaders Prof. Heinz Köppl – Self-Organizing Systems Prof. Felix Hausch – Structure-based Drug Research Prof. Andreas Blaeser – Biomedical Printing Technology Prof. Torsten Frosch
-
and development of cutting-edge (bio)materials and technologies such as nano-/micro-sized delivery systems, hydrogel- and bacterial nanocellulose-based patches, biodegradable and biocompatible
-
for the treatment of infection-triggered inflammatory states, centred on a rational design of tailor-made nanoparticulate drug carriers. Pharmacologically active nanoparticles based on functional synthetic polymers